Clinical trial
Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy…
NCT00083512 · National Cancer Institute (NCI), NIH · Recruiting
Key facts
| NCT number | NCT00083512 |
|---|---|
| Title | Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme |
| Official title | Urinary and Serum VEGF and MMP Levels in Patients Receiving Radiation Therapy for Glioblastoma Multiforme: Prospective Determination of a Predictive Value for Recurrence |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Glioblastoma Multiforme |
| Enrollment | 200 |
| Start date | Jun 22, 2004 |
| First posted | May 25, 2004 |
| Last update posted | Dec 31, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 10–99 FDA inspections linked to this trial
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: